Taken together with the data obtained using H3122/CR-1 cells in this study, MET activation in cancer progression might be a common phenomenon to render cancer cells more malignant, especially with respect to aspects of metastasis, without affecting the response to drugs. The gene discussed is MET; the disease is cancer.